Management team
The people running it
Jacques-Pierre Moreau, D.Sc.
Chief Executive Officer & Co-Founder
Former Chief Science Officer at Ipsen Pharmaceuticals; promoter of multiple spinouts (Preglem, Funxional Therapeutics, Radius, Rhythm Pharmaceuticals); Director at Dr. Reddy’s Labs.
Parth Patwari, M.D., Sc.D.
Chief Scientific Officer & Co-Founder
Prior Harvard Medical School faculty position; trained in the tissue engineering laboratory at MIT; fifteen years of experience in bioengineering, soft tissue biology and osteoarthritis.
Kevin McArdle
Chief Financial Officer (contract)
Abdellah Sentissi, Ph.D.
Quality Consultant (contract)
Board of directors
Founders and investors
Richard T. Lee, M.D.
Co-Founder & Chairman
Professor of Stem Cell and Regenerative Biology at Harvard University; Professor of Medicine at Harvard Medical School; leader of the Cardiovascular Program of the Harvard Stem Cell Institute.
Jacques-Pierre Moreau, D.Sc.
Co-Founder
Former Chief Science Officer at Ipsen Pharmaceuticals; promoter of multiple spinouts; Director at Dr. Reddy’s Labs.
Parth Patwari, M.D., Sc.D.
Co-Founder, Chief Scientific Officer
Prior Harvard Medical School faculty position; trained in the tissue engineering laboratory at MIT.
Michal Votruba
Director, Gradus Fund
Board Member and Director of Global Business Development at Primecell, a.s.; nine years of experience in the global pharmaceutical industry.
Scientific advisors
Rheumatology and gout
Lee Simon, MD
Principal, SDG LLC
Former FDA Division Director, Division of Pulmonary, Allergy and Rheumatology Products.
Robert Terkeltaub, MD
Professor of Medicine, University of California, San Diego
Naomi Schlesinger, MD
Professor of Medicine, Chief of Rheumatology, Rutgers University
N. Larry Edwards, MD
Professor of Medicine, University of Florida
CEO of the Gout & Uric Acid Education Society.
Joseph Flood, MD
Columbus Arthritis Center